Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates.

Autor: King DA; Northwell Health Cancer Institute and Feinstein Institute of Research, Lake Success, NY., Smith AR; Xilis Corporation, Durham, NC., Pineda G; Stanford Cancer Institute, Stanford, CA., Nakano M; Department of Medicine, Divisions of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA., Michelini F; Memorial Sloan Kettering Cancer Center, NY, NY., Goedegebuure SP; Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO., Thyparambil S; Mprobe, Inc, Rockville, MD., Liao WL; Mprobe, Inc, Rockville, MD., McCormick A; Department of Medicine, Divisions of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA., Ju J; Department of Medicine, Divisions of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA., Cioffi M; Cornell University, School of Medicine, New York, NY., Zhang X; Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO., Hundal J; Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO., Griffith M; Department of Medicine, Washington University School of Medicine, St Louis, MO., Grandori C; SEngine Precision Medicine, Seattle, WA., Pollastro M; SEngine Precision Medicine, Seattle, WA., Rosati R; SEngine Precision Medicine, Seattle, WA., Margossian A; SEngine Precision Medicine, Seattle, WA., Chatterjee P; SEngine Precision Medicine, Seattle, WA., Ainge T; SEngine Precision Medicine, Seattle, WA., Flory M; Department of Radiology, Stanford University, Stanford, CA., Ocampo P; Personalized Healthcare, Genentech, Inc, South San Francisco, CA., Chen LM; Department of Gynecologic Oncology, University of California at San Francisco, San Francisco, CA., Poultsides GA; Department of Surgery, Section of Surgical Oncology, Stanford University, Stanford, CA., Baron AD; Division of Hematology Oncology, California Pacific Medical Center, San Francisco, CA., Chang DT; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, CA., Herman JM; Department of Radiation Oncology and Northwell Health Cancer Institute, Lake Success, NY., Gillanders WE; Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO., Park H; Department of Medicine, Division of Oncology, Washington University School of Medicine in St Louis., Hoos WA; xCures Inc, Oakland, CA., Nichols M; Independent Clinician, Saratoga, CA., Fisher GA; Stanford Cancer Institute, Stanford, CA., Kuo CJ; Stanford Cancer Institute, Stanford, CA.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2023 Apr; Vol. 7, pp. e2100489.

A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative.

Autor: Pishvaian MJ; Perthera, Inc, McLean, VA, USA.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Joseph Bender R; Perthera, Inc, McLean, VA, USA., Matrisian LM; The Pancreatic Cancer Action Network, Manhattan Beach, CA, USA., Rahib L; The Pancreatic Cancer Action Network, Manhattan Beach, CA, USA., Hendifar A; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hoos WA; The Pancreatic Cancer Action Network, Manhattan Beach, CA, USA., Mikhail S; Ohio State University, Columbus, OH, USA., Chung V; City of Hope Cancer Center, Duarte, CA, USA., Picozzi V; Virginia Mason Medical Center, Seattle, WA, USA., Heartwell C; Perthera, Inc, McLean, VA, USA., Mason K; Perthera, Inc, McLean, VA, USA., Varieur K; Perthera, Inc, McLean, VA, USA., Aberra M; Perthera, Inc, McLean, VA, USA., Madhavan S; Perthera, Inc, McLean, VA, USA.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Petricoin E 3rd; Perthera, Inc, McLean, VA, USA., Brody JR; Perthera, Inc, McLean, VA, USA.; Jefferson Pancreatic, and Related Cancer Center, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Publikováno v: Oncotarget [Oncotarget] 2016 Nov 08; Vol. 8 (48), pp. 83446-83456. Date of Electronic Publication: 2016 Nov 08 (Print Publication: 2017).

Pancreatic cancer clinical trials and accrual in the United States.

Autor: Hoos WA; All authors: Pancreatic Cancer Action Network, Manhattan Beach, CA., James PM, Rahib L, Talley AW, Fleshman JM, Matrisian LM

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Sep 20; Vol. 31 (27), pp. 3432-8. Date of Electronic Publication: 2013 Aug 19.

Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information.

Autor: Hamamoto, Ryuji^1,2 (AUTHOR) rhamamot@ncc.go.jp, Koyama, Takafumi³ (AUTHOR), Kouno, Nobuji^1,4 (AUTHOR), Yasuda, Tomohiro^1,5 (AUTHOR), Yui, Shuntaro^1,5 (AUTHOR), Sudo, Kazuki^3,6 (AUTHOR), Hirata, Makoto⁷ (AUTHOR), Sunami, Kuniko⁸ (AUTHOR), Kubo, Takashi⁸ (AUTHOR), Takasawa, Ken^1,2 (AUTHOR), Takahashi, Satoshi^1,2 (AUTHOR), Machino, Hidenori^1,2 (AUTHOR), Kobayashi, Kazuma^1,2 (AUTHOR), Asada, Ken^1,2 (AUTHOR), Komatsu, Masaaki^1,2 (AUTHOR), Kaneko, Syuzo^1,2 (AUTHOR), Yatabe, Yasushi^9,10 (AUTHOR), Yamamoto, Noboru³ (AUTHOR)

Publikováno v: Experimental Hematology & Oncology. 10/31/2022, Vol. 11 Issue 1, p1-23. 23p.

Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer.

Autor: Lu, Siyuan^1,2,3,4 (AUTHOR), Hua, Jie^1,2,3,4 (AUTHOR), Liu, Jiang^1,2,3,4 (AUTHOR), Wei, Miaoyan^1,2,3,4 (AUTHOR), Liang, Chen^1,2,3,4 (AUTHOR), Meng, Qingcai^1,2,3,4 (AUTHOR), Zhang, Bo^1,2,3,4 (AUTHOR), Yu, Xianjun^1,2,3,4 (AUTHOR), Wang, Wei^1,2,3,4 (AUTHOR) wangwei@fudanpci.org, Xu, Jin^1,2,3,4 (AUTHOR) xujin@fudanpci.org

Publikováno v: BMC Cancer. 7/21/2022, Vol. 22 Issue 1, p1-19. 19p.